Cardiovascular diseases are the leading cause of death in the United States, and atherosclerotic disease, including coronary and peripheral artery disease (CAD/PAD), costs the US billions of dollars annually.
Join Janssen Pharmaceuticals, Inc. on Wednesday, July 15, 2020, at 2:00 p.m. ET, for a webinar on Understanding High Risk Coronary and Peripheral Artery Disease (CAD and PAD) Patient Populations
What this webinar will cover:
· Brief overview of CAD/PAD, a major health concern that costs the country billions in healthcare spending each year.
· Current guidelines for management
· Opportunities for improvement in care
· Use of targeted risk assessment tools to identify high-risk patients